// App-Quantinova.ai

: Development of Humanized CD19-Chimeric Antigen Receptor for B Cell Malignancy

Researchers

Presenter

  • Vibhuti Vyas

Principal Investigators

  • Lawrence Stern

  • Laura Lim

  • Christian Huynh

  • Ryan Urak

  • John C Williams

  • Stephen J Forman

  • Christine E Brown

  • Xiuli Wang

Medical Centers

  • Department of Molecular Medicine, City of Hope National Medical Center, Duarte

  • Cellular Immunotherapy Center, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Non-Hodgkin's Lymphoma

  • Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 4

  • Epidermal growth factor receptor

  • Interferon-gamma

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A


Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A